MSLN and ovarian carcinoma: Here, we found that high MSLN expression levels are associated with the presence of ascites and shorter progression-free survival in epithelial ovarian cancer (EOC) patients and that primary and matched peritoneal metastasis of HGSC share MSLN overexpression.